Similar articles

• [Autologous bone marrow transplantation in pediatric oncology].

  Wagner HP, Baumgartner C, Bleher EA, Brun del Re G, Bucher U, Deubelbeiss KA, Greiner R, Hirt A, Imbach P, Lüthy A, Odavic R. Wagner HP, et al. Monatsschr Kinderheilkd. 1982 Nov;130(11):814-6. Monatsschr Kinderheilkd. 1982. PMID: 6759924 German. No abstract available.
• High-dose melphalan therapy for the treatment of children with refractory neuroblastoma and Ewing's sarcoma.

  Graham-Pole J, Lazarus HM, Herzig RH, Gross S, Coccia P, Weiner R, Strandjord S. Graham-Pole J, et al. Am J Pediatr Hematol Oncol. 1984 Spring;6(1):17-26. Am J Pediatr Hematol Oncol. 1984. PMID: 6370012
• [High-dosage melphalan followed by bone marrow autotransplant in solid tumors of childhood: our experience].

  Sánchez de Toledo Codina J, Gallego Melcón S, Pérez Payarols J, Prats Viñas J, Javier G, Massuet L, Macià Martí J. Sánchez de Toledo Codina J, et al. Med Clin (Barc). 1986 Apr 19;86(15):621-3. Med Clin (Barc). 1986. PMID: 3014240 Spanish. No abstract available.
• [Autologous bone marrow graft in solid tumors in childhood].

  Devalck C, Ferster A, De Laet MH, Nafa S, Bujan W, Azzi N, Ben Salah H, Corrazza F, Vergauwen P, Sariban E. Devalck C, et al. Rev Med Brux. 1992 Jun;13(6):201-6. Rev Med Brux. 1992. PMID: 1321485 Review. French.
• Biology and treatment of pediatric malignant solid tumors.

  Marina NM. Marina NM. Cancer Chemother Biol Response Modif. 1997;17:642-71. Cancer Chemother Biol Response Modif. 1997. PMID: 9551234 Review. No abstract available.